19:41 , May 16, 2019 |  BC Extra  |  Company News

Genentech adds to autoimmune pipeline with Parvus deal

In its second deal based on its immunomodulatory platform, Parvus granted Genentech rights to develop and commercialize its Navacim nanoparticle therapeutics to treat inflammatory bowel disease (IBD), autoimmune liver diseases and celiac disease. Parvus Therapeutics...
14:14 , Mar 25, 2019 |  BioCentury  |  Emerging Company Profile

China Oncology Focus: funding combinations

China Oncology Focus aims to differentiate itself from other Chinese in-licensing plays by leveraging the diversity of its pipeline to develop in-house combination therapies, with its PD-L1 therapy as a backbone. The company is seeking...
22:59 , Nov 30, 2018 |  BioCentury  |  Emerging Company Profile

Afyx: Mucosal drug delivery

Afyx Therapeutics is developing bioadhesive patches for mucosal drug delivery to address diseases that are inadequately treated by topical agents. Diseases affecting topically accessible mucosal sites, such as the buccal mucosa, are difficult to treat...
20:06 , Oct 5, 2018 |  BC Week In Review  |  Financial News

ArunA raises $5.3M

ArunA Biomedical Inc. (Athens, Ga.) said it raised $5.3 million from existing undisclosed angel investors. ArunA’s neural exosome platform allows drugs and drug combinations to cross the blood brain barrier. The company announced in January...
21:44 , Oct 4, 2018 |  BC Innovations  |  Emerging Company Profile

Banking on exosomes

Alxerion Biotech LLC is building a biobank of exosomes from diverse species as a comprehensive source for therapeutics discovery. Its initial focus is on cancer. The company aims to collect and screen 350,000 samples from...
18:16 , Aug 31, 2018 |  BC Week In Review  |  Financial News

Real-world data play RDMD raises $3M seed round

RDMD (San Francisco, Calif.) raised $3 million on Aug. 20 in a seed round led by new investor Lux Capital, with participation from existing investor Village Globe and new investors First Round's Healthcare Co-Op, Garuda...
11:02 , Aug 20, 2018 |  BC Extra  |  Financial News

Real-world data play RDMD raises $3M seed round

RDMD (San Francisco, Calif.) raised $3 million in a seed round led by new investor Lux Capital, with participation from existing investor Village Globe and new investors First Round's Healthcare Co-Op, Garuda and Shasta Ventures....
19:11 , Jul 27, 2018 |  BioCentury  |  Emerging Company Profile

Wound-up bacteria

Ilya Pharma AB has engineered bacteria to produce a protein that promotes wound closure as a more convenient and lower cost alternative to recombinant protein therapies that accelerate wound healing. According to CEO Evelina Vågesjö,...
17:31 , Jul 20, 2018 |  BC Week In Review  |  Financial News

MS play Octave adds Scangos to board, raises $14M series A

Multiple sclerosis company Octave Bioscience Inc. (Menlo Park, Calif.) raised $14 million on July 12 in a series A round led by new investor BlueCross BlueShield Venture Partners. Echo Health Ventures, Section 32 and other...
00:33 , Jul 13, 2018 |  BC Extra  |  Financial News

MS play Octave adds Scangos to board, raises $14M series A

Multiple sclerosis company Octave Bioscience Inc. (Menlo Park, Calif.) raised $14 million in a series A round led by new investor BlueCross BlueShield Venture Partners. Echo Health Ventures, Section 32 and other new and existing...